GORE Flexible Freeze Container Biopharmaceutical Advancements

Due to the worldwide response to COVID-19-related R&D; increased development of novel therapeutics; and the expansion of cell and gene therapy innovations, biopharma manufacturers are seeing significant manufacturing momentum.

woman speaks to a smartphone

Learn how Gore developed an innovative solution that provides industry-leading particle protection and acoustic performance to help the world’s largest smartphone OEM and MEMS microphone manufacturers solve a critical predicament.

woman speaks to a smartphone

Thank you for your interest in our case study. The link to your document is below. Do not hesitate to contact us for any questions or support needed.

Your Gore Mobile Electronics Team

Press Release

AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies

Posted December 12, 2022

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A affinity purification technology from Gore alongside the global CDMO’s contract development and manufacturing services. By using GORE and AGC Biologics, biopharmaceutical companies can improve downstream purification processes, eliminate column bioburden issues, increase product material yields in the research and development (R&D) stages, and help lower costs for clinical manufacturing.

GORE Flexible Freeze Container gas ingress

For many emerging cell and gene therapies, their increasing sensitivity and how that may impact stability have made their storage and transport uniquely challenging. This complexity has led to pioneering new container technologies designed for increasingly complex biologics; while the space had been historically dominated by bottles, closed multilayer bag assemblies and, more recently, single-layer fluoropolymer bags have become the more attractive choice for companies with colder storage and transport temperature requirements.

News

Propelling Your Downstream Purification

Posted December 7, 2022

WL Gore and AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), recently announced a powerful collaboration. The partnership brings the GORE® Protein Capture Devices with Protein A as an integral component in the AGC Biologics’ mAb-based CDMO services. The combined offering from GORE and AGC Biologics is available across the CDMO’s global network.

Gore's breakthrough discovery - ePTFE

Gore's expanded polymer membrane technology, known for its durability and performance, was a breakthrough discovery by Bob Gore in 1969. Since then, Gore's continuous innovation has evolved into many innovative membrane technologies used in numerous industries. Discover how our advanced materials engineering expertise is helping to improve the lives of people around the world.

Event

Join us at the Sensor Symposium in Dresden, Germany

Join us at the Sensor Symposium in Dresden, Germany. As one of the event sponsors we invite you to stop by any time to meet with our team at the Sensor Symposium in Dresden.

Subscribe to Content
Top